A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients-Reference-Cited by-同舟云学术

A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients

Published:2018-02 Issue: Volume:81 Page:122-130
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Huang Manli,Yu Liang,Pan Fen,Lu Shaojia,Hu Shaohua,Hu Jianbo,Chen Jinkai,Jin Pingbo,Qi Hongli,Xu Yi

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference52 articles.

1. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics;Almeras;J. Clin. Psychiatry,2004

2. Focus on prolactin as a metabolic hormone;Ben-Jonathan;Trends Endocrinol. Metab.,2006

3. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives;Byerly;J. Clin. Psychopharmacol.,2007

4. A review of paliperidone palmitate;Chue;Expert. Rev. Neurother.,2012

5. Endogenic and iatrogenic diabetes mellitus in drug-naive schizophrenia: the role of olanzapine and its place in the psychopharmacological treatment algorithm;Cohen;Neuropsychopharmacology,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis;Psychiatry Research;2024-10

2. Schizophrenia and Heart Health: Are Antipsychotics a Friend or Foe?;Journal of Personalized Medicine;2024-07-31

3. Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis;Therapeutic Advances in Psychopharmacology;2024-01

4. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics);Tasman’s Psychiatry;2024

5. Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis;Frontiers in Psychiatry;2023-06-27